GH1 and cancer: Additionally, studies by Guevara‐Aguirre and colleagues reveal that humans with Laron Syndrome (LS) who are GH‐resistant, have enhanced insulin sensitivity, are resistant to diabetes and cancer, and show a significant reduction in pro‐aging markers (Guevara‐Aguirre et al., 2011).